Gradient Investments LLC Editas Medicine, Inc. Transaction History

Gradient Investments LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 26, 2022	SELL	$14.08 - $27.63 $3,520 - $6,907	-250 Closed	0 $0
Q2 2020 Jul 10, 2020	SELL	$18.5 - $34.34 $3,422 - $6,352	-185 Reduced 42.53%	250 $7,000
Q1 2020 Apr 07, 2020	BUY	$14.88 - $32.78 $3,720 - $8,195	250 Added 135.14%	435 $9,000
Q4 2019 Jan 15, 2020	SELL	$19.49 - $32.63 $2,728 - $4,568	-140 Reduced 43.08%	185 $5,000
Q2 2019 Jul 16, 2019	BUY	$20.48 - $27.76 $6,656 - $9,022	325 New	325 $8,000
Q2 2018 Aug 09, 2018	SELL	$31.4 - $41.01 $125 - $164	-4 Closed	0 $0
Q4 2017 Feb 07, 2018	BUY	$21.89 - $31.34 $87 - $125	4	4 $0

248

57M

410K

394K

Ticker EDIT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 68,737,200
Market Cap $90M
Description
Editas Medicine, Inc., a clinical stage genome editing company, focuses on developing transformative genomic medicines to treat a range of serious diseases. It develops a proprietary gene editing platform based on CRISPR technology. The company develops EDIT-101, which is in Phase 1/2 clinical trial for Leber Congenital Amaurosis 10 that leads t...

Get notified when there are updates to the investment portfolio of Gradient Investments LLC, based on Form 13F filings with the SEC.

Stay updated on Gradient Investments LLC with notifications on news.